Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/04/2012CA2432971C Polypeptides
09/04/2012CA2271169C Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity
09/04/2012CA2243261C Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions
09/04/2012CA2196999C Treatment of type ii diabetes mellitus with amylin agonists
09/03/2012CA2734014A1 Cold sore formulation and related method of manufacture
08/2012
08/30/2012WO2012116370A1 Methods and systems using pharmacokinetic and pharmacodynamic profiles in interferon-alpha therapeutic regimens
08/30/2012WO2012116362A2 Chalcone derivatives as nrf2 activators
08/30/2012WO2012116357A2 Use of agr3 for treating cancer
08/30/2012WO2012116282A2 Protein nanocarriers for topical delivery
08/30/2012WO2012116260A1 Methods of identifying a patient population
08/30/2012WO2012116210A2 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus
08/30/2012WO2012116203A1 Water soluble membrane proteins and methods for the preparation and use thereof
08/30/2012WO2012116064A1 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
08/30/2012WO2012116018A1 Spray dried myrosinase and use to produce isothiocyanates
08/30/2012WO2012115940A2 A method of inducing hematopoietic reconstruction
08/30/2012WO2012115772A2 Therapy for kidney disease and/or heart failure
08/30/2012WO2012115771A2 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides
08/30/2012WO2012115715A2 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
08/30/2012WO2012115659A1 Compositions and methods for controlled delivery of compounds
08/30/2012WO2012115640A1 Liquid insulin- containing compositions and methods of making the same
08/30/2012WO2012115637A1 Aspart proinsulin compositions and methods of producing aspart insulin analogs
08/30/2012WO2012115439A2 Composition comprising expression or activity regulators of akap12 for treating central nerve system diseases
08/30/2012WO2012115437A2 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target
08/30/2012WO2012115208A1 Glp-1 analogue composition for microneedle devices
08/30/2012WO2012115207A1 Biologically active nonaqueous composition for microneedle devices, and biologically active nonaqueous composition adhering to microneedle
08/30/2012WO2012115185A1 Composition for treatment, amelioration or prophylaxis of pain
08/30/2012WO2012115159A1 Polypeptide compound
08/30/2012WO2012115118A1 Polypeptide compound
08/30/2012WO2012114339A1 High affinity molecules capable of binding a type a plexin receptor and uses of same
08/30/2012WO2012114131A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld)
08/30/2012WO2012114051A1 Cutaneous pharmaceutical compositions for the local treatment of canine atopic dermatitis
08/30/2012WO2012113963A1 Use of p53 inhibitors for reducing food intake and lowering body weight
08/30/2012WO2012113785A1 Methods for treating and diagnosing disease
08/30/2012WO2012113775A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
08/30/2012WO2012113286A1 A glp-1 analogue, its preparation methods and use thereof
08/30/2012WO2012113236A1 Use and method of hepatocyte nuclear factor 1α for treating chronic liver diseases
08/30/2012WO2012113117A1 Oral preparation comprising protein or polypeptide, preparation method thereof, and use thereof
08/30/2012WO2012113116A1 Emulsion containing hydrophilic biological macromolecule, preparation method and application thereof
08/30/2012WO2012113061A1 Cancer diagnosis and treatment
08/30/2012WO2012113037A1 Method for inhibiting proteins
08/30/2012WO2012113022A1 Therapeutic uses of slirp
08/30/2012WO2012088608A8 Compositions comprising natriuretic peptides and methods of use thereof
08/30/2012WO2012088222A3 Methods and compositions for producing active vitamin k-dependent proteins
08/30/2012WO2012085259A3 Antimicrobial agents
08/30/2012WO2012054929A3 Use of human serum albumin to decrease antigenicity of therapeutic proteins
08/30/2012WO2012021796A8 Novel cyclosporin derivatives for the treatment and prevention of a viral infection
08/30/2012US20120222141 Islet1 (isl1) and hearing loss
08/30/2012US20120220646 Treatment of Cancer by Inhibition of IGFBPs and Clusterin
08/30/2012US20120220601 Delta opioid receptor agonist compounds
08/30/2012US20120220542 Pegylated c-peptide
08/30/2012US20120220540 Synbodies to akt1
08/30/2012US20120220539 Conotoxin peptides
08/30/2012US20120220538 Lunasin-containing complex and purification of lunasin from plants
08/30/2012US20120220537 9-aminoacridine derivatives, their preparation and uses
08/30/2012US20120220536 Use of endostatin peptides for the treatment of fibrosis
08/30/2012US20120220535 Cyclic-glur6 analogs, methods of treatment and use
08/30/2012US20120220534 Biomarker for neurodegeneration in neurological disease
08/30/2012US20120220533 Modulating neuromuscular junction density changes in botulinum-toxin treated tissue
08/30/2012US20120220532 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
08/30/2012US20120220531 Surfactant protein d for the treatment of disorders associated with lung injury
08/30/2012US20120220530 Albumin variants
08/30/2012US20120220529 Nitric oxide-blocked cross-linked tetrameric hemoglobin
08/30/2012US20120220528 Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides
08/30/2012US20120220527 Methods and materials for reducing platelet counts and/or platelet adhesion
08/30/2012US20120220526 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and other Disorders
08/30/2012US20120220525 Stablized Melanocortin Ligands
08/30/2012US20120220524 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
08/30/2012US20120220523 Use of a corn peptidi hydrolyzate as an active agent stimulating hair growth
08/30/2012US20120220522 Ester insulin
08/30/2012US20120220520 Bioavailable combinations for hcv treatment
08/30/2012US20120220519 Peptide Aptamers that Bind to the Rep Proteins of ssDNA Viruses
08/30/2012US20120220518 Therapeutic agent delivery system and method
08/30/2012US20120220517 Glycopegylation Methods and Proteins/Peptides Produced by the Methods
08/30/2012US20120219965 Masp 2, a complement-fixing enzyme, and uses for it
08/30/2012US20120219956 Ngal for diagnosis of renal conditions
08/30/2012US20120219641 5-ht3 receptor modulators, methods of making, and use thereof
08/30/2012US20120219629 Compositions and methods for controlled delivery of compounds
08/30/2012US20120219621 Composition with Enhanced Thermogenic Activity and the Use Thereof in the Prevention and Treatment of Obesity
08/30/2012US20120219616 LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
08/30/2012US20120219615 Therapeutic Use of a TLR Agonist and Combination Therapy
08/30/2012US20120219612 Mineral Technologies (MT) for Acute Hemostasis and for the Treatment of Acute Wounds and Chronic Ulcers
08/30/2012US20120219603 Use of Calcitonin for the Treatment of RA
08/30/2012US20120219601 Composition Comprising Biodegradable Hydrating Ceramics for Controlled Drug Delivery
08/30/2012US20120219589 Formulation of drugs and vaccines in the form of percutaneous injectable needles
08/30/2012US20120219574 Antigen surrogates in autoimmune disease
08/30/2012US20120219573 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
08/30/2012US20120219568 Epidithiodioxopiprazines and uses thereof in treating cancer
08/30/2012US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219559 Methods of modulating immune function
08/30/2012US20120219554 Extracellular yaluronidase from streptomyces koganeiensis
08/30/2012US20120219544 Adhesive composition for soft tissues, adhesive composition for wound dressing or wound dressing composition
08/30/2012US20120219542 Podocyte ph modulation and uses thereof
08/30/2012US20120219540 Compositions and methods for modulating immune responses
08/30/2012US20120219538 Stabilized protein formulations and use thereof
08/30/2012US20120219537 Method For Repairing DNA Damage In Keratinocytes
08/30/2012US20120219536 Purine-targeted diagnosis and therapy of wounds
08/30/2012US20120219534 Freeze-dried fibrin matrices and methods for preparation thereof
08/30/2012US20120219528 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
08/30/2012US20120219525 Stable thickener formulations
1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 3163